<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03515668</url>
  </required_header>
  <id_info>
    <org_study_id>17-123</org_study_id>
    <nct_id>NCT03515668</nct_id>
  </id_info>
  <brief_title>Dopamine and Muscle Function in the Heat</brief_title>
  <official_title>The Influence of Dopamine Activity on Neuromuscular Function During Passive Heat Stress</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brock University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brock University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      our goal is to study the effects of dopamine activity, using Ritalin ingestion, on&#xD;
      neuromuscular function over the course of a progressive heating and cooling protocol&#xD;
      developed in our lab. We hypothesize that Ritalin will minimize the previously reported&#xD;
      progressive impairment in neuromuscular function with hyperthermia compared to placebo,&#xD;
      suggesting that dopamine activity preserves neuromuscular capacity with hyperthermia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Increased core temperature (hyperthermia) has been associated with impaired neuromuscular&#xD;
      performance, with the majority of research suggesting that the observed fatigue is related to&#xD;
      the central nervous system. Small doses of Ritalin has been used to study how changes in&#xD;
      dopamine activity affects exercise capacity in the heat. This study found that 20 mg of&#xD;
      Ritalin had no effect on exercise capacity in a thermoneutral environment of 18°C. However,&#xD;
      when in a hot (30°C) environment, the Ritalin resulted in a 16% improvement in finishing time&#xD;
      compared to the placebo trial. Interestingly, the higher output during the Ritalin-hot&#xD;
      condition also resulted in higher rates of heat production and a higher (~0.6°C) core&#xD;
      temperature, suggesting that dopamine enabled greater voluntary tolerance of hyperthermia.&#xD;
      This matches recent work from our own work showing that motivational skills training&#xD;
      increased both exercise tolerance and final core temperature, and it is possible that&#xD;
      dopamine activity played a role in this improvement.&#xD;
&#xD;
      Ultimately, fatigue is shown in an inability to sustain muscular force. However, the role of&#xD;
      dopamine activity on neuromuscular function (e.g., central activation and recruitment of&#xD;
      muscle) during hyperthermia is unknown. One study reported that 20 mg of Ritalin did not&#xD;
      alter neuromuscular function, but this study was done without thermal stress.&#xD;
&#xD;
      Therefore, our goal is to study the effects of dopamine activity, using Ritalin ingestion, on&#xD;
      neuromuscular function over the course of a progressive heating and cooling protocol&#xD;
      developed in our lab. We hypothesize that Ritalin will minimize the previously reported&#xD;
      progressive impairment in neuromuscular function with hyperthermia (5, 7) compared to&#xD;
      placebo, suggesting that dopamine activity preserves neuromuscular capacity with&#xD;
      hyperthermia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 20, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Healthy males 18-30 years of age</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Double-blinding of participant and investigator, with independent investigator in charge of placebo and drug.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Wrist flexion torque</measure>
    <time_frame>2-4 hours after ingestion</time_frame>
    <description>Maximal voluntary contraction of wrist flexion</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Muscle Force</condition>
  <condition>Hyperthermia</condition>
  <arm_group>
    <arm_group_label>Ritalin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 mg Ritalin, 90 min before testing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Identical size/taste placebo pill, 90 min before testing</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ritalin 20 mg Tablet</intervention_name>
    <description>Single dose for all participants</description>
    <arm_group_label>Ritalin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Oral Tablet</intervention_name>
    <description>Placebo with same appearance/taste</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  High aerobic fitness (&gt;55 mL/kg/min maximal aerobic capacity)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  diagnosed cardiovascular, respiratory and/or neuromuscular disease, prescription of&#xD;
             Ritalin or any drugs for hyperactivity within the past 1 year, any current&#xD;
             prescription medication (except for asthma/allergy inhalers), any contraindications to&#xD;
             Ritalin.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Brock University</name>
      <address>
        <city>St Catharines</city>
        <state>Ontario</state>
        <zip>L2S 3A1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>April 23, 2018</study_first_submitted>
  <study_first_submitted_qc>April 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2018</study_first_posted>
  <last_update_submitted>February 8, 2021</last_update_submitted>
  <last_update_submitted_qc>February 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brock University</investigator_affiliation>
    <investigator_full_name>Stephen Cheung</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperthermia</mesh_term>
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylphenidate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No sharing planned</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

